Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...

Stage IIIA: Cancer has spread to the submucosa or muscle and to one to three nearby lymph nodes or tissue near the lymph nodes, referred to as "deposits." Or cancer has spread to the submucosa and ...

Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and ...

Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

Oral submucous fibrosis (OSF) is a chronic condition commonly affecting the oral mucosa, causing an excessive buildup of collagen that disrupts tissue ... deeper into the submucosa as the disease ...

“These findings reinforce that the duodenal mucosa and submucosa are critical therapeutic ... energy to treat inflamed and dysfunctional tissue associated with type 2 diabetic duodenopathy.

A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery ...